Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0000899243-20-012444

Co-CEO and Director acquired 6,459 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Chintu Co-CEO and Director 2020-05-07 Option exercise +6,459 362,566 D
Derivatives
Patel Chintu Co-CEO and Director 2020-05-07 Option exercise · Restricted Stock Units −6,459 0 D
Loading xslF345X03/doc4.xml…